VAV Life Sciences

Name

VAV Life Sciences

Legal name

M S VAV Life Sciences Pvt. Ltd.

Website

https://vav.in

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Lipid Excipients

NAICS

Fats and Oils Refining and Blending (311225), Soybean and Other Oilseed Processing (311224), Medicinal and Botanical Manufacturing (325411), Starch and Vegetable Fats and Oils Manufacturing (31122)

SIC

Fats & Oils (2070), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Phospholipids & Lecithin Systems (Deoiled Lecithin, Fractionated Lecithins) (AFAJALAL)

akta.pro secondary industries

Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation) (AFAJACAL), Lipid-Based Emulsions & Encapsulated Oils (Spray-Dried Oils, Microencapsulation) (AFAJALAM), Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried) (AFAJAKAL), Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI)

Keywords

• Phospholipid manufacturing
• Lecithin ingredients supply
• Liposomal delivery systems
• Pharmaceutical excipients
• Lipid nanoparticle production

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Ingredient Sales: B2B sales of phospholipids, synthetic lipids, and lipid-based delivery systems to pharmaceutical companies for use in drug formulations, injectable emulsions, and active pharmaceutical ingredients.
2. Nutraceutical Ingredient Sales: Sale of phospholipids, lecithins, and liposomal delivery systems to nutrition and supplement manufacturers for functional food, beverage, and nutraceutical applications.
3. Cosmetic & Personal Care Ingredient Sales: Supply of phospholipid-based ingredients and liposomal systems to cosmetic and personal care product manufacturers for advanced skincare and dermatological formulations.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

VAV Life Sciences manufactures and supplies phospholipids, lecithins, synthetic lipids, and pre-formulated liposomal delivery systems derived from soy, sunflower, and egg sources. The company serves pharmaceutical, nutrition, and cosmetic manufacturers globally with ingredients for injectable emulsions, parenteral nutrition, advanced drug delivery (including lipid nanoparticles for mRNA therapeutics), bioavailability-enhanced nutraceuticals, and skin-penetration cosmetic formulations. Operations are GMP-certified and the product range spans commodity lecithins through ultra-pure injectable-grade phosphatidylcholines and ready-to-use liposomal actives.

Product overview

VAV Life Sciences is a leading manufacturer of phospholipids, lecithins, and lipid-based delivery systems serving pharmaceutical, nutrition & health, and cosmetic & personal care industries. The product portfolio includes Natural Phospholipids & Lecithins (LECIVA brand from soybean, sunflower, and egg sources), Synthetic Lipids (including DSPC, DPPC, DMPC, and anionic lipids), Neutral Lipids & Oils (cholesterol and OLEOVA egg oil), Choline Alfoscerate (Alpha-GPC) for cognitive health, and ready-to-use Phospholipid Systems including liposomal delivery complexes (LECIVA-CurLip, LECIVA-AscoLip, LECIVA-D3Lip, and others). Their products enable efficient incorporation of actives into stable, scalable formulations for drug delivery, nutritional supplements, and cosmetic applications.

Differentiator

Problem solved

Functional benefit

Brands

• LECIVA: Product line for natural phospholipids, lecithins, synthetic lipids, and related lipid ingredients sourced from soybean, sunflower, and egg. Includes variants like LECIVA-S (soy), LECIVA-M (sunflower), LECIVA-D (synthetic/specific phospholipids), LECIVA-PRO, LECIVA-IMMIX, and liposomal ingredient products such as LECIVA-AscoLip (vitamin C), LECIVA-CurLip (curcumin), LECIVA-GluLip (glutathione), and LECIVA-D3Lip (vitamin D3).
• LIPOVA
• LECIVA-GPC

Products and services

• Natural Phospholipids & Lecithins (LECIVA brand)

Quantifiable outcome

• Liposomal vitamin C demonstrates >2.5X higher Cmax, 6X longer Tmax, and 41X higher AUC compared to conventional vitamin C
• +5 more outcomes

Named customers21 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Lipoid GmbH: German phospholipid specialist with a near-identical product portfolio spanning natural (soy/sunflower/egg) lecithins, synthetic phospholipids, and liposomal systems for pharmaceutical, nutraceutical, and cosmetic applications. The closest comparable peer in technology, customer segments, and B2B ingredient positioning.
• Kewpie Corporation: Japanese food and pharmaceutical company with significant egg-derived phospholipid and lecithin manufacturing. Direct competitor in egg phospholipids (LIPOVA-equivalent product line) and in injectable emulsion excipient supply.
• Sternchemie: German lecithin and phospholipid manufacturer specializing in soy and sunflower lecithins for food, nutrition, and pharmaceutical applications. Highly comparable in product range, B2B ingredient model, and customer overlap.
• Fuji Oil Group: Japanese specialist in oilseed-derived ingredients including soy and sunflower lecithins/phospholipids for food and nutrition applications. Competes directly in the natural phospholipid and emulsifier line of business.
• NOF Corporation: Japanese manufacturer of pharmaceutical-grade phospholipids and lipid excipients (including PEGylated lipids) used in liposomal injectables and mRNA delivery. Directly competes in the synthetic phospholipid and LNP space.
• Avanti Polar Lipids (Croda): Specializes in high-purity natural and synthetic phospholipids for pharmaceutical and research applications, now part of Croda. Direct competitor in injectable-grade and LNP-relevant lipid excipients serving the same pharmaceutical customer base.

Emerging players

• CordenPharma: CDMO with growing capabilities in lipid nanoparticle formulation for mRNA and gene therapy. An emerging buyer/supply-chain participant in the LNP space that competes for the same biotech customers VAV serves with synthetic lipid excipients.

Broad incumbents

• Evonik (Specialty Additives): German specialty chemicals company with lipid-based excipients and pharmaceutical delivery systems. Overlaps in synthetic phospholipids and lipid excipients for pharma but as part of a much broader specialty chemicals portfolio.
• ADM (Animal Nutrition & Specialty Ingredients): Major oilseed processor with lecithin and phospholipid offerings as part of a broad food/feed ingredient portfolio. Competes in commodity-grade lecithin but lacks VAV's depth in pharmaceutical-grade and liposomal systems.
• Cargill (Lecithin & Specialty Oils): Global agricultural commodity and ingredient giant with a significant lecithin/oilseed processing business. Overlaps in food-grade and feed-grade lecithins but does not specialize in VAV's pharmaceutical/injectable-grade or liposomal delivery niche.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/LipidsVav
• YouTubeyoutube.com/@VAVLifeSciences
• LinkedInlinkedin.com/company/m-s.-vav-life-sciences-pvt.-ltd.
• Facebookfacebook.com/profile.php

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VAV Life Sciences